APA (7th ed.) Citation

Tefferi, A., Al-Ali, H. K., Barosi, G., Devos, T., Gisslinger, H., Jiang, Q., . . . Gale, R. P. (2017). A randomized study of pomalidomide vs placebo in persons with myeloproliferative neoplasm-associated myelofibrosis and RBC-transfusion dependence. Leukemia, 31(4), 896-902. https://doi.org/10.1038/leu.2016.300

Chicago Style (17th ed.) Citation

Tefferi, A., et al. "A Randomized Study of Pomalidomide Vs Placebo in Persons with Myeloproliferative Neoplasm-associated Myelofibrosis and RBC-transfusion Dependence." Leukemia 31, no. 4 (2017): 896-902. https://doi.org/10.1038/leu.2016.300.

MLA (9th ed.) Citation

Tefferi, A., et al. "A Randomized Study of Pomalidomide Vs Placebo in Persons with Myeloproliferative Neoplasm-associated Myelofibrosis and RBC-transfusion Dependence." Leukemia, vol. 31, no. 4, 2017, pp. 896-902, https://doi.org/10.1038/leu.2016.300.